{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:42:50Z","timestamp":1791218570265,"version":"4.1.0"},"reference-count":159,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.nano.2026.102913","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T16:17:02Z","timestamp":1771690622000},"page":"102913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Emerging nanocarrier platforms in Cervical cancer therapy: From Molecular targeting to Precision Nanomedicine"],"prefix":"10.1016","volume":"73","author":[{"given":"Samidha","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naman","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10167","key":"10.1016\/j.nano.2026.102913_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"issue":"39","key":"10.1016\/j.nano.2026.102913_bb0010","doi-asserted-by":"crossref","first-page":"8163","DOI":"10.2174\/0929867327666201111145546","article-title":"E6 and E7 oncoproteins: potential targets of cervical cancer","volume":"28","author":"Malla","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nano.2026.102913_bb0015","author":"Tan"},{"key":"10.1016\/j.nano.2026.102913_bb0020","author":"Ojha"},{"key":"10.1016\/j.nano.2026.102913_bb0025","series-title":"Strategies for overcoming chemotherapy resistance in cervical cancer","first-page":"17","article-title":"Current treatment options and limitations for cervical cancer","author":"Bida","year":"2024"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0030","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ygyno.2021.06.006","article-title":"Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2\u20134 cm; emerging data and future perspectives","volume":"162","author":"Gwacham","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"18","key":"10.1016\/j.nano.2026.102913_bb0035","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.3390\/cancers17183057","article-title":"Cervical cancer treatment and fertility: what we know and what we do","volume":"17","author":"Habib","year":"2025","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/cancers14030575","article-title":"Management of early-stage cervical cancer: a literature review","volume":"14","author":"Guimar\u00e3es","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.nano.2026.102913_bb0045","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14737140.2024.2337259","article-title":"Recent advances in photodynamic therapy combined with chemotherapy for cervical cancer: a systematic review","volume":"24","author":"Carobeli","year":"2024","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0055","article-title":"Recent trends in Nanocarrier-based targeted chemotherapy: selective delivery of anticancer drugs for effective lung, colon, cervical, and breast Cancer treatment","volume":"2020","author":"Jin","year":"2020","journal-title":"J Nanomater"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0060","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2016.27.e43","article-title":"Advances in diagnosis and treatment of metastatic cervical cancer","volume":"27","author":"Li","year":"2016","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1568009611313020009","article-title":"Current and potential treatments for cervical cancer","volume":"13","author":"P.C. Yee","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.nano.2026.102913_bb0070","doi-asserted-by":"crossref","DOI":"10.2147\/OTT.S25123","article-title":"Targeted treatments for cervical cancer: a review","author":"Peralta-Zaragoza","year":"2012","journal-title":"Onco Targets Ther"},{"issue":"27","key":"10.1016\/j.nano.2026.102913_bb0075","doi-asserted-by":"crossref","first-page":"22195","DOI":"10.1021\/acsami.7b04982","article-title":"Block copolymer based nanoparticles for theranostic intervention of cervical cancer: synthesis, pharmacokinetics, and in vitro\/in vivo evaluation in HeLa xenograft models","volume":"9","author":"Dumoga","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"issue":"9","key":"10.1016\/j.nano.2026.102913_bb0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3390\/gels9090713","article-title":"Imiquimod-loaded chitosan-decorated di-block and tri-block polymeric nanoparticles loaded in situ gel for the management of cervical cancer","volume":"9","author":"Almomen","year":"2023","journal-title":"Gels"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0085","article-title":"HPV-associated cervical cancer cells targeted by triblock copolymer gold nanoparticle curcumin combination","volume":"38","author":"Chen-Sandoval","year":"2017","journal-title":"Eur J Gynaecol Oncol"},{"issue":"9","key":"10.1016\/j.nano.2026.102913_bb0090","article-title":"Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy","volume":"22","author":"Mendes","year":"2017","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.nano.2026.102913_bb0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/nano6060116","article-title":"Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization","volume":"6","author":"Lomis","year":"2016","journal-title":"Nanomaterials"},{"issue":"11","key":"10.1016\/j.nano.2026.102913_bb0100","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/17425247.2022.2134341","article-title":"Current trends in the use of human serum albumin for drug delivery in cancer","volume":"19","author":"Paul","year":"2022","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cryst13040637","article-title":"Synthesis of bimetallic nanoparticles and applications\u2014an updated review","volume":"13","author":"Idris","year":"2023","journal-title":"Crystals"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jksus.2017.06.012","article-title":"Novel development of nanoparticles to bimetallic nanoparticles and their composites: a review","volume":"31","author":"Sharma","year":"2019","journal-title":"J King Saud Univ Sci"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0115","article-title":"Update on the use of nanocarriers and drug delivery systems and future directions in cervical cancer","volume":"2022","author":"Himiniuc","year":"2022","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.apsb.2023.08.033","article-title":"Plant-derived nanovesicles as an emerging platform for cancer therapy","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0125","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389450116666150722141607","article-title":"Nanocarriers based anticancer drugs: current scenario and future perceptions","volume":"17","author":"Raj","year":"2016","journal-title":"Curr Drug Targets"},{"issue":"16","key":"10.1016\/j.nano.2026.102913_bb0130","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/CM9.0000000000003703","article-title":"Advances in nanocarrier-mediated cancer therapy: progress in immunotherapy, chemotherapy, and radiotherapy","volume":"138","author":"Peng","year":"2025","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/20550324.2024.2362504","article-title":"Navigating the novel nanoparticles: current insights, innovations, and future vistas in detection and treatment of cervical cancer","volume":"10","author":"Devi","year":"2024","journal-title":"Nanocomposites"},{"key":"10.1016\/j.nano.2026.102913_bb0140","author":"S\u00e1nchez-Meza"},{"key":"10.1016\/j.nano.2026.102913_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.03.014","article-title":"Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies","volume":"102","author":"Ho","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.nano.2026.102913_bb0150","article-title":"Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer","volume":"1","author":"Vasconcellos","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.nano.2026.102913_bb0155","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ejso.2006.03.037","article-title":"Management of cervical cancer","volume":"32","author":"Kesic","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.nano.2026.102913_bb0160","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14737140.2015.1079777","article-title":"Neoadjuvant chemotherapy in cervical cancer: an update","volume":"15","author":"Lapresa","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3390\/jcm8020156","article-title":"Neoadjuvant chemotherapy with taxane and platinum followed by radical hysterectomy for stage IB2-IIB cervical cancer: impact of histology type on survival","volume":"8","author":"Matsuo","year":"2019","journal-title":"J Clin Med"},{"issue":"2 PART 1","key":"10.1016\/j.nano.2026.102913_bb0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/AOG.0b013e31827c5822","article-title":"Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis","volume":"121","author":"Zagouri","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02635-y","article-title":"Clinical effects of cervical conization with positive margins in cervical cancer","volume":"11","author":"Nagao","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0180","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/IGC.0000000000000991","article-title":"Conization in early stage cervical cancer: pattern of recurrence in a 10-year single-institution experience","volume":"27","author":"Tomao","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0185","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/AOG.0000000000003952","article-title":"Radical trachelectomy for the treatment of early-stage cervical cancer: a systematic review","volume":"136","author":"Smith","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.nano.2026.102913_bb0190","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/ijgc-2020-001782","article-title":"Radical trachelectomy","volume":"31","author":"Segarra-Vidal","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0195","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2011.08.009","article-title":"Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience","volume":"123","author":"Maneo","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.18433\/J30C7D","article-title":"Nanotherapeutics to overcome conventional cancer chemotherapy limitations","volume":"14","author":"Chidambaram","year":"2011","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.nano.2026.102913_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.103415","article-title":"Molecular patho-mechanisms of cervical cancer (MMP1)","volume":"77","author":"Kurnia","year":"2022","journal-title":"Ann Med Surg"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0210","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10311-018-00841-1","article-title":"Nanocarriers for drug delivery applications","volume":"17","author":"Chamundeeswari","year":"2019","journal-title":"Environ Chem Lett"},{"key":"10.1016\/j.nano.2026.102913_bb0215","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.2147\/IJN.S146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors","volume":"12","author":"Din","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/pharmaceutics14010018","article-title":"An up-to-date review of natural nanoparticles for cancer management","volume":"14","author":"Ion","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0225","doi-asserted-by":"crossref","first-page":"0394","DOI":"10.36922\/gtm.0394","article-title":"Advances in nanoparticle-based drug delivery in cancer treatment","volume":"2","author":"Sarvari","year":"2023","journal-title":"Glob Transl Med"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0230","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4172\/1948-5956.1000024","article-title":"The use of nanocarriers for drug delivery in cancer therapy","volume":"2","author":"Khan","year":"2010","journal-title":"J Cancer Sci Ther"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0235","first-page":"e167","article-title":"siRNA as a conventional drug in the clinic? Challenges and current technologies","volume":"9","author":"Shim","year":"2012","journal-title":"Drug Discov Today Technol Formulation Technol Overcome Poor Drug-like Prop"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0240","first-page":"187","article-title":"Therapeutic siRNA: principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J Biol Med"},{"issue":"23","key":"10.1016\/j.nano.2026.102913_bb0245","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1111\/j.1742-4658.2010.07905.x","article-title":"Staying on message: design principles for controlling nonspecific responses to siRNA","volume":"277","author":"Samuel-Abraham","year":"2010","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1567201811666140822112516","article-title":"Nanomedicines based drug delivery systems for anti-cancer targeting and treatment","volume":"12","author":"Jain","year":"2015","journal-title":"Curr Drug Deliv"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0255","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/pharmaceutics16050674","article-title":"Novel drug delivery systems: an important direction for drug innovation research and development","volume":"16","author":"Chen","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5138\/09750215.1974","article-title":"EPR effect based nanocarriers targeting for treatment of cancer","volume":"8","author":"Gajbhiye","year":"2017","journal-title":"Int J Drug Deliv"},{"key":"10.1016\/j.nano.2026.102913_bb0265","series-title":"Cancer targeted drug delivery","first-page":"621","article-title":"The EPR effect in cancer therapy","author":"Yhee","year":"2013"},{"issue":"6","key":"10.1016\/j.nano.2026.102913_bb0270","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2019020396","article-title":"Solid lipid nanoparticles: vital characteristics and prospective applications in cancer treatment","volume":"36","author":"Laz\u0103r","year":"2019","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0275","doi-asserted-by":"crossref","DOI":"10.5138\/ijdd.2010.0975.0215.02029","article-title":"Solid lipid nanoparticles in cancer therapy","volume":"2","author":"Mathur","year":"2010","journal-title":"Int J Drug Deliv"},{"issue":"7","key":"10.1016\/j.nano.2026.102913_bb0280","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.3390\/ijms24076199","article-title":"Solid lipid nanoparticles: applications and prospects in cancer treatment","volume":"24","author":"Sivadasan","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0285","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/nano9030474","article-title":"Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs","volume":"9","author":"Bay\u00f3n-Cordero","year":"2019","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0290","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1573413719666230413084140","article-title":"Nanotechnology-based drug delivery systems for the treatment of cervical cancer: a comprehensive review","volume":"20","author":"Singhai","year":"2024","journal-title":"Curr Nanosci"},{"issue":"16","key":"10.1016\/j.nano.2026.102913_bb0295","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.2174\/1871520623666230626145750","article-title":"Design and evaluation of SLNs encapsulated curcumin-based topical formulationfor the management of cervical cancer","volume":"23","author":"Singhai","year":"2023","journal-title":"Anticancer Agents Med Chem"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0300","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nano.2009.12.006","article-title":"Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy","volume":"6","author":"Kang","year":"2010","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"10.1016\/j.nano.2026.102913_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107320","article-title":"Development of permeation enhancer-co-loaded solid lipid nanoparticles for enhanced oral bioavailability of alendronate","volume":"113","author":"Kim","year":"2025","journal-title":"J Drug Delivery Sci Technol"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/nano8020110","article-title":"Development and characterization of solid lipid nanoparticles loaded with a highly active doxorubicin derivative","volume":"8","author":"Stella","year":"2018","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0315","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1574886308666131223123218","article-title":"Anti-Cancer, pharmacokinetic and biodistribution studies of cremophor EL free alternative paclitaxel formulation","volume":"9","author":"Jain","year":"2013","journal-title":"Curr Drug Saf"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/br.2025.2010","article-title":"Therapies and nanotherapies for cervical cancer (review)","volume":"23","author":"S\u00e1nchez-Meza","year":"2025","journal-title":"Biomed Rep"},{"key":"10.1016\/j.nano.2026.102913_bb0325","doi-asserted-by":"crossref","DOI":"10.1039\/D5PM00109A","article-title":"Solid lipid nanoparticles in cervical cancer: a comprehensive review of a decade of progress and prospects","author":"Tiwary","year":"2025","journal-title":"RSC Pharm"},{"key":"10.1016\/j.nano.2026.102913_bb0330","series-title":"RNA interference and cancer therapy","first-page":"303","article-title":"Vaginal suppositories with siRNA and paclitaxel-incorporated solid lipid nanoparticles for cervical cancer: preparation and in vitro evaluation","volume":"vol. 1974","author":"B\u00fcy\u00fckk\u00f6ro\u011flu","year":"2019"},{"key":"10.1016\/j.nano.2026.102913_bb0335","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/IJN.S115136","article-title":"Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer","volume":"12","author":"Liu","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0340","doi-asserted-by":"crossref","DOI":"10.1080\/20022727.2017.1335567","article-title":"Possible role of nanocarriers in drug delivery against cervical cancer","volume":"8","author":"Gupta","year":"2017","journal-title":"Nano Rev Exp"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbcan.2010.02.004","article-title":"Carbon nanotubes in cancer diagnosis and therapy","volume":"1806","author":"Ji","year":"2010","journal-title":"Biochim Biophys Acta (BBA) Rev Cancer"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/1556-276X-8-267","article-title":"Delivery of small interfering RNAs in human cervical cancer cells by polyethylenimine-functionalized carbon nanotubes","volume":"8","author":"Huang","year":"2013","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0355","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1477-3155-9-45","article-title":"Single wall carbon nanotubes enter cells by endocytosis and not membrane penetration","volume":"9","author":"Yaron","year":"2011","journal-title":"J Nanobiotechnol"},{"issue":"12","key":"10.1016\/j.nano.2026.102913_bb0360","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1039\/C5NR00220F","article-title":"Diameter-dependent release of a cisplatin pro-drug from small and large functionalized carbon nanotubes","volume":"7","author":"Muzi","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2026.102913_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107393","article-title":"Adsorption and encapsulation of melittin on covalently functionalized carbon nanotubes; a molecular dynamics simulation study","volume":"166","author":"Kordzadeh","year":"2023","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.nano.2026.102913_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112800","article-title":"Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: advancements and future perspectives","volume":"206","author":"Sameer Khan","year":"2024","journal-title":"Eur Polym J"},{"key":"10.1016\/j.nano.2026.102913_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.121393","article-title":"Folic acid functionalized carbon nanotubes as pH controlled carriers of fluorouracil: molecular dynamics simulations","volume":"377","author":"Yahyavi","year":"2023","journal-title":"J Mol Liq"},{"key":"10.1016\/j.nano.2026.102913_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.cartre.2025.100464","article-title":"Development and evaluation of folic acid conjugated curcumin-loaded functionalized multiwalled carbon nanotubes for enhanced efficacy in ovarian cancer treatment","volume":"19","author":"Chattaraj","year":"2025","journal-title":"Carbon Trends"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0385","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/molecules23040938","article-title":"Dendrimers for drug delivery","volume":"23","author":"Chauhan","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1409","article-title":"Dendrimer-based nanocarriers: a versatile platform for drug delivery","volume":"9","author":"Hsu","year":"2017","journal-title":"WIREs Nanomed Nanobiotechnol"},{"issue":"17","key":"10.1016\/j.nano.2026.102913_bb0395","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.3390\/molecules25173982","article-title":"Applications and limitations of dendrimers in biomedicine","volume":"25","author":"Chis","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0400","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11705-017-1623-5","article-title":"Molecular engineering of dendrimer nanovectors for siRNA delivery and gene silencing","volume":"11","author":"Cao","year":"2017","journal-title":"Front Chem Sci Eng"},{"issue":"47","key":"10.1016\/j.nano.2026.102913_bb0405","doi-asserted-by":"crossref","first-page":"16264","DOI":"10.1021\/jacs.8b10021","article-title":"A dual targeting dendrimer-mediated siRNA delivery system for effective gene silencing in cancer therapy","volume":"140","author":"Dong","year":"2018","journal-title":"J Am Chem Soc"},{"issue":"8","key":"10.1016\/j.nano.2026.102913_bb0410","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.nano.2014.05.008","article-title":"Targeted delivery of dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system","volume":"10","author":"Liu","year":"2014","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0415","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2018.05.045","article-title":"Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA\/siRNA for cancer therapy","volume":"546","author":"Li","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102913_bb0420","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actbio.2016.07.015","article-title":"PEGylated PAMAM dendrimers: enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery","volume":"43","author":"Luong","year":"2016","journal-title":"Acta Biomater"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0425","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11051-019-4486-5","article-title":"PEGylated poly(amidoamine) dendrimers-based drug loading vehicles for delivering carboplatin in treatment of various cancerous cells","volume":"21","author":"Ho","year":"2019","journal-title":"J Nanopart Res"},{"issue":"10","key":"10.1016\/j.nano.2026.102913_bb0430","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.mattod.2015.06.003","article-title":"PAMAM dendrimers as promising nanocarriers for RNAi therapeutics","volume":"18","author":"Kesharwani","year":"2015","journal-title":"Mater Today"},{"key":"10.1016\/j.nano.2026.102913_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110762","article-title":"Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells","volume":"188","author":"Ghaffari","year":"2020","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0440","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-82074-7","article-title":"Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer","volume":"15","author":"Aghanejad","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102913_bb0445","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.saa.2013.02.003","article-title":"Investigation on the interaction behavior between curcumin and PAMAM dendrimer by spectral and docking studies","volume":"108","author":"Cao","year":"2013","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"10.1016\/j.nano.2026.102913_bb0450","series-title":"Pharmaceutical applications of dendrimers","first-page":"151","article-title":"7 - cancer-targeted chemotherapy: emerging role of the folate anchored dendrimer as drug delivery nanocarrier","author":"Rajani","year":"2020"},{"key":"10.1016\/j.nano.2026.102913_bb0455","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2018.12.069","article-title":"Biotin functionalized PEGylated poly (amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer","volume":"557","author":"Rompicharla","year":"2019","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0460","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1021\/acsabm.0c00179","article-title":"Cell-penetrating peptide and \u03b1-tocopherol-conjugated poly(amidoamine) dendrimers for improved delivery and anticancer activity of loaded paclitaxel","volume":"3","author":"Bhatt","year":"2020","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.nano.2026.102913_bb0465","author":"muley"},{"key":"10.1016\/j.nano.2026.102913_bb0470","author":"Paul"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0475","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1007\/s12668-024-01496-9","article-title":"Polymeric nanostructures revolutionizing cervical cancer: diagnostics, therapeutics, and theranostics","volume":"14","author":"Dey","year":"2024","journal-title":"BioNanoScience"},{"issue":"26","key":"10.1016\/j.nano.2026.102913_bb0480","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1039\/C4TB00171K","article-title":"Dendrimers for drug delivery","volume":"2","author":"Caminade","year":"2014","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2026.102913_bb0485","article-title":"Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis","volume":"525","author":"Satya Prakash","year":"2010","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.nano.2026.102913_bb0490","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jconrel.2023.12.057","article-title":"Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy","volume":"366","author":"Zheng","year":"2024","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.nano.2026.102913_bb0495","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1080\/17425247.2016.1193149","article-title":"Albumin nanostructures as advanced drug delivery systems","volume":"13","author":"Karimi","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"issue":"17","key":"10.1016\/j.nano.2026.102913_bb0500","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.3390\/ijms26178297","article-title":"Human serum albumin-based nanoparticles for targeted intracellular drug delivery","volume":"26","author":"Chilom","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.nano.2026.102913_bb0505","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/03639045.2025.2509861","article-title":"Combating breast cancer-associated metastasis using paclitaxel and tranilast-loaded human serum albumin nanoparticles","volume":"51","author":"Jain","year":"2025","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0510","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2012.09.008","article-title":"Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: a gynecologic oncology group study","volume":"127","author":"Alberts","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.nano.2026.102913_bb0515","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/14656566.2020.1724284","article-title":"Advances in paclitaxel combinations for treating cervical cancer","volume":"21","author":"Della Corte","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0520","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00432-024-05764-9","article-title":"Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer","volume":"150","author":"Zhao","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0525","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/jps.23455","article-title":"A novel self-assembly albumin nanocarrier for reducing doxorubicin-mediated cardiotoxicity","volume":"102","author":"Yuan","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2026.102913_bb0530","series-title":"Functionalization of monodisperse magnetic nanoparticles","author":"Lattuada","year":"2007"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0535","doi-asserted-by":"crossref","first-page":"60","DOI":"10.22159\/ijpps.2017v9i5.17261","article-title":"Folic acid-conjugated doxorubicin-loaded photosensitizing manganese ferrite nanoparticles: synthesis, characterization and anticancer activity against human cervical carcinoma cell line (HELA)","volume":"9","author":"Safdar","year":"2017","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.nano.2026.102913_bb0540","author":"Wu"},{"issue":"6","key":"10.1016\/j.nano.2026.102913_bb0545","first-page":"1991","article-title":"20(s)-ginsenoside Rg3-loaded magnetic human serum albumin nanospheres applied to HeLa cervical cancer cells in vitro","volume":"24","author":"Yang","year":"2014","journal-title":"Biomed Mater Eng"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122581","article-title":"Enhanced gene silencing through human serum albumin-mediated delivery of polyethylenimine-siRNA polyplexes","volume":"10","author":"Nicol\u00ec","year":"2015","journal-title":"PloS One"},{"issue":"17","key":"10.1016\/j.nano.2026.102913_bb0555","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1039\/D0TB00327A","article-title":"Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity","volume":"8","author":"Zhang","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2026.102913_bb0560","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2147\/DDDT.S112039","article-title":"Novel curcumin-loaded human serum albumin nanoparticles surface functionalized with folate: characterization and in vitro\/vivo evaluation","volume":"10","author":"Dong","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.nano.2026.102913_bb0565","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijbiomac.2019.02.129","article-title":"Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells","volume":"130","author":"Saleh","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2026.102913_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.105178","article-title":"Folic acid-conjugated cancer drug curcumin-loaded albumin nanoparticles: investigation of curcumin release kinetics","volume":"91","author":"T\u00fcrke\u015f","year":"2024","journal-title":"J Drug Delivery Sci Technol"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0575","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17425247.2015.993313","article-title":"Albumin and its application in drug delivery","volume":"12","author":"Sleep","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0580","first-page":"7","article-title":"Hydrogels as drug delivery systems; pros and cons","volume":"5","author":"Ghasemiyeh","year":"2019","journal-title":"Trends Pharm Sci Technol"},{"key":"10.1016\/j.nano.2026.102913_bb0585","author":"Andrade"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0590","first-page":"373","article-title":"Hydrogel-based controlled drug delivery for cancer treatment: a review","volume":"17","author":"Sun","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2026.102913_bb0595","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2022.01.035","article-title":"PCL-PEG copolymer based injectable thermosensitive hydrogels","volume":"343","author":"Dethe","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102913_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120954","article-title":"Thermo-responsive hydrogels for cancer local therapy: challenges and state-of-art","volume":"606","author":"Rafael","year":"2021","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0605","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201902785","article-title":"Smart injectable hydrogels for cancer immunotherapy","volume":"30","author":"Chao","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.nano.2026.102913_bb0610","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3389\/fchem.2019.00675","article-title":"Injectable hydrogels for localized cancer therapy","volume":"7","author":"Fan","year":"2019","journal-title":"Front Chem"},{"key":"10.1016\/j.nano.2026.102913_bb0615","author":"Jamal"},{"key":"10.1016\/j.nano.2026.102913_bb0620","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2022.07.038","article-title":"Customizing nano-chitosan for sustainable drug delivery","volume":"350","author":"Saeedi","year":"2022","journal-title":"J Control Release"},{"issue":"9","key":"10.1016\/j.nano.2026.102913_bb0625","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1080\/10717544.2016.1205158","article-title":"Vaginal delivery of carboplatin-loaded thermosensitive hydrogel to prevent local cervical cancer recurrence in mice","volume":"23","author":"Wang","year":"2016","journal-title":"Drug Deliv"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0630","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/acsbiomaterials.1c01399","article-title":"A three-dimensional printable hydrogel formulation for the local delivery of therapeutic nanoparticles to cervical cancer","volume":"8","author":"Kiseleva","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0635","doi-asserted-by":"crossref","first-page":"35","DOI":"10.22270\/jddt.v8i5.1886","article-title":"Niosomes: present scenario and future aspects","volume":"8","author":"Kaur","year":"2018","journal-title":"J Drug Deliv Ther"},{"issue":"17","key":"10.1016\/j.nano.2026.102913_bb0640","doi-asserted-by":"crossref","first-page":"9668","DOI":"10.3390\/ijms23179668","article-title":"Current advances in specialised niosomal drug delivery: manufacture, characterization and drug delivery applications","volume":"23","author":"Witika","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102913_bb0645","article-title":"Current advances in niosomes applications for drug delivery and cancer treatment","volume":"23","author":"Moammeri","year":"2023","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.nano.2026.102913_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2023.127336","article-title":"Smart pH-responsive magnetic graphene quantum dots nanocarriers for anticancer drug delivery of curcumin","volume":"297","author":"Seyyedi Zadeh","year":"2023","journal-title":"Mater Chem Phys"},{"key":"10.1016\/j.nano.2026.102913_bb0655","author":"You"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0660","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202402599","article-title":"Investigation of the apoptotic and antimetastatic effects of nano-niosomes containing the plant extract Anabasis setifera on HeLa: in vitro cervical cancer study","volume":"22","author":"Ebadi","year":"2025","journal-title":"Chem Biodivers"},{"issue":"6","key":"10.1016\/j.nano.2026.102913_bb0665","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1021\/acsanm.8b00468","article-title":"Theranostic niosomes as a promising tool for combined therapy and diagnosis: \u201call-in-one\u201d approach","volume":"1","author":"Demir","year":"2018","journal-title":"ACS Appl Nano Mater"},{"issue":"7","key":"10.1016\/j.nano.2026.102913_bb0670","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1021\/acsapm.4c00238","article-title":"Glycopolymeric photoactive micelles for glucose transporter-targeted synergistic combination therapy","volume":"6","author":"Gencoglu Katmerlikaya","year":"2024","journal-title":"ACS Appl Polym Mater"},{"issue":"10","key":"10.1016\/j.nano.2026.102913_bb0675","article-title":"Empowering cancer therapy: comparing PEGylated and non-PEGylated niosomes loaded with curcumin and doxorubicin on MCF-7 cell line","volume":"10","author":"Saharkhiz","year":"2023","journal-title":"Bioengeenering"},{"issue":"12","key":"10.1016\/j.nano.2026.102913_bb0680","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10856-021-06623-6","article-title":"In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes","volume":"32","author":"Barani","year":"2021","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.nano.2026.102913_bb0685","series-title":"Nanotechnology for Drug Delivery and Pharmaceuticals","first-page":"187","article-title":"Recent plant-based nanomedicine and nanocarrier for cancer treatment","author":"Shukla","year":"2023"},{"key":"10.1016\/j.nano.2026.102913_bb0690","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.2147\/IJN.S499893","article-title":"From plant based therapy to plant-derived vesicle-like nanoparticles for cancer treatment: past, present and future","volume":"20","author":"An","year":"2025","journal-title":"Int J Nanomedicine"},{"issue":"14","key":"10.1016\/j.nano.2026.102913_bb0695","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3390\/cells11142232","article-title":"Emergence of edible plant-derived nanovesicles as functional food components and nanocarriers for therapeutics delivery: potentials in human health and disease","volume":"11","author":"Kim","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.nano.2026.102913_bb0700","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1007\/s12010-024-04872-z","article-title":"Investigation of in vitro anti-cancer and apoptotic potential of onion-derived nanovesicles against prostate and cervical cancer cell lines","volume":"196","author":"Sharma","year":"2024","journal-title":"Appl Biochem Biotechnol"},{"issue":"5","key":"10.1016\/j.nano.2026.102913_bb0705","article-title":"In vitro evaluation of seaweed gracilaria verrucosa for cytotoxic activity against cervical HeLa cells","volume":"10","author":"Dewi","year":"2018","journal-title":"Pharm J"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0710","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.3390\/molecules20046573","article-title":"Methanolic extracts from brown seaweeds Dictyota cilliolata and Dictyota menstrualis induce apoptosis in human cervical adenocarcinoma HeLa cells","volume":"20","author":"Gomes","year":"2015","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0715","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/ijms22020629","article-title":"Are bioactive molecules from seaweeds a novel and challenging option for the prevention of HPV infection and cervical Cancer therapy?\u2014a review","volume":"22","author":"Moga","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2026.102913_bb0720","author":"ashwini"},{"issue":"2","key":"10.1016\/j.nano.2026.102913_bb0725","doi-asserted-by":"crossref","first-page":"575","DOI":"10.31557\/APJCP.2024.25.2.575","article-title":"Investigation of in-vitro anti-cancer and apoptotic potential of garlic-derived nanovesicles against prostate and cervical cancer cell lines","volume":"25","author":"Sharma","year":"2024","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0730","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7150\/thno.10257","article-title":"Aptamers: active targeting ligands for cancer diagnosis and therapy","volume":"5","author":"Wu","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2026.102913_bb0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/5426974","article-title":"Recent advances in identifying biomarkers and high-affinity aptamers for gynecologic cancers diagnosis and therapy","volume":"2019","author":"Ma","year":"2019","journal-title":"J Anal Methods Chem"},{"issue":"3","key":"10.1016\/j.nano.2026.102913_bb0740","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12038-016-9632-y","article-title":"Application of aptamers in diagnostics, drug-delivery and imaging","volume":"41","author":"Chandola","year":"2016","journal-title":"J Biosci"},{"issue":"12","key":"10.1016\/j.nano.2026.102913_bb0745","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.tibtech.2011.06.009","article-title":"Molecular aptamers for drug delivery","volume":"29","author":"Tan","year":"2011","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2026.102913_bb0750","author":"Carvalho"},{"key":"10.1016\/j.nano.2026.102913_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118511","article-title":"AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells","volume":"568","author":"Figueiredo","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102913_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116257","article-title":"Recent advances on G-quadruplex for biosensing, bioimaging and cancer therapy","volume":"139","author":"Xu","year":"2021","journal-title":"TrAC Trends Anal Chem"},{"key":"10.1016\/j.nano.2026.102913_bb0765","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ijbiomac.2019.11.118","article-title":"Therapeutic applications of AS1411 aptamer, an update review","volume":"155","author":"Yazdian-Robati","year":"2020","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"10.1016\/j.nano.2026.102913_bb0770","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/med.21462","article-title":"Anti-MUC1 aptamer: a potential opportunity for cancer treatment","volume":"37","author":"Nabavinia","year":"2017","journal-title":"Med Res Rev"},{"issue":"4","key":"10.1016\/j.nano.2026.102913_bb0775","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036103","article-title":"Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells","volume":"7","author":"Graham","year":"2012","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.nano.2026.102913_bb0780","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/nprot.2010.66","article-title":"Development of DNA aptamers using cell-SELEX","volume":"5","author":"Sefah","year":"2010","journal-title":"Nat Protoc"},{"issue":"2\u20133","key":"10.1016\/j.nano.2026.102913_bb0785","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00239-019-9886-8","article-title":"In vitro selection of a DNA aptamer by cell-SELEX as a molecular probe for cervical cancer recognition and imaging","volume":"87","author":"Wang","year":"2019","journal-title":"J Mol Evol"},{"issue":"12","key":"10.1016\/j.nano.2026.102913_bb0790","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1021\/acs.molpharmaceut.9b00717","article-title":"Transferrin-functionalized microemulsions coloaded with coix seed oil and tripterine deeply penetrate to improve cervical cancer therapy","volume":"16","author":"Guo","year":"2019","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.nano.2026.102913_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/ph19010074","article-title":"Functionalized core\/shell gold-palladium bimetallic nanoparticles in transferrin-targeted dual-drug delivery in a cervical cancer cell model","volume":"19","author":"David","year":"2025","journal-title":"Pharmaceuticals"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:24:01Z","timestamp":1776309841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":159,"alternative-id":["S1549963426000146"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102913","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging nanocarrier platforms in Cervical cancer therapy: From Molecular targeting to Precision Nanomedicine","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102913"}}